Essential Thrombocythemia
Essential Thrombocythemia is a VA-ratable condition under diagnostic code 7718 in the Blood & Lymphatic System category. Maximum rating: 100%.
Rating Criteria
| Rating | Criteria |
|---|---|
| 100% | Requiring either continuous myelosuppressive therapy or, for 6 months following hospital admission, peripheral blood or bone marrow stem cell transplant, or chemotherapy, or interferon treatment. |
| 70% | Requiring continuous or intermittent myelosuppressive therapy, or chemotherapy, or interferon treatment to maintain platelet count <500 × 109/L. |
| 30% | Requiring continuous or intermittent myelosuppressive therapy, or chemotherapy, or interferon treatment to maintain platelet count of 200,000-400,000, or white blood cell (WBC) count of 4,000-10,000. |
| 0% | No symptoms. |
Filing Tips
Pro Tip: The VA won't connect the dots for you. That's your job. Build the paper trail before you file.
Gather medical evidence showing a current diagnosis of this condition.
Document in-service events, injuries, or exposures that caused or aggravated this condition.
Consider a nexus letter from a medical professional linking your condition to service.
Review the rating criteria for DC 7718 to understand what symptoms warrant higher ratings.
Quick Links
Related Conditions
Acquired Agranulocytosis
DC 7702
Acquired hemolytic anemia
DC 7723
Acute Nonlymphocytic Leukemia
DC 7719
Addison's Anemia
DC 7722
Adenitis, tuberculous
DC 7710
Agranulocytosis
DC 7702
Agranulocytosis, acquired
DC 7702
Agranulosis
DC 7702